BioDelivery Sciences International, Inc. (BDSI)
BDSIPrice: $5.59
Fair Value: 🔒
🔒score
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive ... more
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the develop... more
Description
Shares
| Market Cap | $577.05M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Herm Cukier |
| IPO Date | 2002-07-25 | CAGR | 0.46% |
| Employees | 200 | Website | www.bdsi.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
BDSI chart loading...
Fundamentals
Technicals
| Enterprise Value | $252.38M | P/E Ratio | 6.82 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 3.46 | P/B Ratio | 3.07 |
| P/CF Ratio | 14.07 | P/FCF Ratio | 14.21 |
| EPS | $0.82 | EPS Growth 1Y | 228% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 6.54% | Gross Margin | 0.86% |
| Operating Margin | 0.22% | Profit Margin | 0.51% |
| ROE | 0.57% | ROA | 0.26% |
| ROCE | 0.15% | Current Ratio | 2.45 |
| Quick Ratio | 2.17 | Cash Ratio | 1.39 |
| Debt/Equity | 0.31 | Interest Coverage | 4.95 |
| Altman Z Score | 2.72 | Piotroski Score | 6 |
View BioDelivery Sciences International, Inc. financial charts →